Found: 19
Select item for more details and to access through your institution.
Questions and Answers About Clozapine, Part 2: A Dialogue About Indications for Clozapine, Managing Adverse Effects, and More.
- Published in:
- 2024
- By:
- Publication type:
- Question & Answer
Questions and Answers About Clozapine: A Dialogue About the Use of Plasma Levels.
- Published in:
- 2024
- By:
- Publication type:
- Question & Answer
The Metabolic Syndrome and Schizophrenia: Clinical Research Update.
- Published in:
- Psychiatric Times, 2007, v. 24, n. 2, p. 29
- By:
- Publication type:
- Article
Risk Factors for Ileus in Patients with Schizophrenia.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Risk Factors for Ileus in Patients with Schizophrenia.
- Published in:
- Schizophrenia Bulletin, 2012, v. 38, n. 3, p. 592, doi. 10.1093/schbul/sbq137
- By:
- Publication type:
- Article
Ciprofloxacin and Clozapine: A Potentially Fatal but Underappreciated Interaction.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Comment on "Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison" [Letter].
- Published in:
- Neuropsychiatric Disease & Treatment, 2023, v. 19, p. 1709, doi. 10.2147/NDT.S430757
- By:
- Publication type:
- Article
An Evidence-Based Update on Anticholinergic Use for Drug-Induced Movement Disorders.
- Published in:
- CNS Drugs, 2024, v. 38, n. 4, p. 239, doi. 10.1007/s40263-024-01078-z
- By:
- Publication type:
- Article
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia.
- Published in:
- CNS Drugs, 2023, v. 37, n. 7, p. 545, doi. 10.1007/s40263-023-01022-7
- By:
- Publication type:
- Article
Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics.
- Published in:
- CNS Drugs, 2011, v. 25, n. 6, p. 473, doi. 10.2165/11587800-000000000-00000
- By:
- Publication type:
- Article
Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder.
- Published in:
- BMC Psychiatry, 2022, v. 22, n. 1, p. 1, doi. 10.1186/s12888-022-03758-w
- By:
- Publication type:
- Article
A survey of personnel and services offered in 32 outpatient US clozapine clinics.
- Published in:
- BMC Psychiatry, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12888-021-03584-6
- By:
- Publication type:
- Article
Weight changes before and after lurasidone treatment: a real-world analysis using electronic health records.
- Published in:
- Annals of General Psychiatry, 2017, v. 16, p. 1, doi. 10.1186/s12991-017-0159-x
- By:
- Publication type:
- Article
Real-world Data on Atypical Antipsychotic Medication Side Effects.
- Published in:
- Psychiatry (1550-5952), 2010, v. 7, n. 7, p. 9
- By:
- Publication type:
- Article
National Security.
- Published in:
- International Lawyer, 2011, v. 45, n. 1, p. 425
- By:
- Publication type:
- Article
Relationship between the timing of relapse and plasma drug levels following discontinuation of cariprazine treatment in patients with schizophrenia: indirect comparison with other second-generation antipsychotics after treatment discontinuation.
- Published in:
- Neuropsychiatric Disease & Treatment, 2019, v. 15, p. 2537, doi. 10.2147/NDT.S210340
- By:
- Publication type:
- Article
Reply.
- Published in:
- Acta Psychiatrica Scandinavica, 2009, v. 120, n. 6, p. 501, doi. 10.1111/j.1600-0447.2009.01413.x
- By:
- Publication type:
- Article
Crossing the Line: The Law of War and Cyber Engagement - An Introduction.
- Published in:
- International Lawyer, 2018, v. 51, n. 3, p. 587
- By:
- Publication type:
- Article
Lumateperone for major depressive episodes in bipolar I or bipolar II disorder.
- Published in:
- Current Psychiatry, 2022, v. 21, n. 3, p. 44, doi. 10.12788/cp.0227
- By:
- Publication type:
- Article